Health surveillance, biosafety and emergence and re-emergence of infectious diseases in Brazil

AUTOR(ES)

Cardoso, Telma Abdalla de Oliveira, Navarro, Marli BM de Albuquerque, Costa Neto, Cristina, Moreira, Josino Costa

FONTE

Brazilian Journal of Infectious Diseases

DATA DE PUBLICAÇÃO

2010-10

RESUMO

The present paper presents compulsory notification data for infectious diseases and epidemiologic ones recorded at the Center for Strategic Information and Health Surveillance (CIEVS) for the period of March 2006 to April 2007. Data is presented in accordance with geographic distribution, time and risk classification of the etiologic agents found, according to Ministry of Health regulations. The importance of this epidemiologic surveillance system is presented, debating the main topics required for quality improvement and information analysis. It is concluded, from the analysis of epidemiologic events and their relation to risk management, that the compulsory notification system in Brazil is incomplete, irregular, delayed and, in a large percentage of cases, notification cannot be completed and the agent may not be identified. Quality of data varies from one region to another and from county to county within the same region. There is a high proportion of cases in which the etiologic agent is unknown and, in such cases, a high lethality is expected, establishing a high risk exposure condition for those health professionals involved in health surveillance. From these data, the study points out the need to improve the surveillance system and strengthens the idea of building maximum containment laboratories

Documentos Relacionados

• The new threats of Gram positive pathogens: re-emergence of things past.
• Wuchereria bancrofti infection in Haitian immigrants and the risk of re-emergence of lymphatic filariasis in the Brazilian Amazon
• Foot-and-mouth disease in Europe: FMD is economically the most important disease of farm animals. Its re-emergence in Europe is likely to have consequences that go beyond severe alterations of livestock production and trade
• Evaluation of reporting timeliness of public health surveillance systems for infectious diseases
• Melanoma, immune surveillance, and immunotherapy.